Hitting the target in IDH2 mutant AML.

doi:10.1182/blood-2017-06-790394

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Hitting the target in IDH2 mutant AML.

Blood - 10 Aug 2017

Wouters Bas J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to IDH2 gene
Share to Isocitrate Dehydrogenase
Share to Leukemia, Myeloid, Acute
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed

Identifiers

PMID: 28798056
DOI: 10.1182/blood-2017-06-790394

Genes

IDH2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hitting the target in IDH2 mutant AML.PMID 28798056Read ↗

T cells take aim in AML: targeting IDH2.Semantic proximity Read ↗

Targeting IDH: the next big thing in AML.Semantic proximity Read ↗

A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML.Semantic proximity Read ↗

Stein EM. IDH2 inhibition in AML. Blood. 2023;141(2):124-125.Semantic proximity Read ↗

Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML.Semantic proximity Read ↗

The curious incident of TdT-mediated mutations in AML.Semantic proximity Read ↗

IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis.Semantic proximity Read ↗

A new player in IDH1 mutated myeloid neoplasias.Semantic proximity Read ↗

Genetic characterization of acute myeloid leukemia patients with mutations in IDH1/2 genes.Semantic proximity Read ↗

Anticancer drugs: IDH2 drives cancer in vivo.Semantic proximity Read ↗

Optimizing Next-Generation AML Therapy: Activity of Mutant IDH2 Inhibitor AG-221 in Preclinical Models.Semantic proximity Read ↗

IDH1 and IDH2: Not Your Typical OncogenesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.